tomeko

Osteogenesis imperfecta with normal sclerae, dominant form

Just diagnosed with Osteogenesis imperfecta with normal sclerae, dominant form?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Osteogenesis imperfecta with normal sclerae, dominant form, look for clinical trials, and connect with others living with it — all in one place.

Open the full Osteogenesis imperfecta with normal sclerae, dominant form hub →

Overview

Osteogenesis imperfecta with normal sclerae, dominant form is a rare condition. Also known as OI type 4. Tomeko brings together the specialists, research, clinical trials, treatments and community for Osteogenesis imperfecta with normal sclerae, dominant form so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:216820 · OMIM 166220, 259440, 610682 · ICD-10 Q78.0 · GARD 0008696

Find care for Osteogenesis imperfecta with normal sclerae, dominant form

Authoritative references for Osteogenesis imperfecta with normal sclerae, dominant form

Common questions

I was just diagnosed with Osteogenesis imperfecta with normal sclerae, dominant form — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Osteogenesis imperfecta with normal sclerae, dominant form, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Osteogenesis imperfecta with normal sclerae, dominant form?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Osteogenesis imperfecta with normal sclerae, dominant form, filtered to your area.

Are there clinical trials for Osteogenesis imperfecta with normal sclerae, dominant form?

Tomeko shows live, recruiting studies for Osteogenesis imperfecta with normal sclerae, dominant form from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com